FAST NEWS: Innocare Pharma Loss Narrows on New Drug’s Contribution
The latest: Drug maker InnoCare Pharma Ltd. (9969.HK) announced Wednesday that its net loss shrank by 83.5% to 64.5 million yuan ($10.1 million) last year from 2020 levels. Looking up: The company…
RELATED ARTICLES
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK -
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
BRIEF: InnoCare revenue jumps 37% in 2024 on strong lymphoma drug sales
9969.HK 688428.SHG
- As Covid drug cash dwindles, Vigonvita targets new remedies
- Cancer drug maker Genfleet joins Hong Kong IPO influx
- Innogen Pharma jostles for a slice of the weight-loss market
- Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
